Clinical Research Directory
Browse clinical research sites, groups, and studies.
Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy
Sponsor: Icahn School of Medicine at Mount Sinai
Summary
A randomized double-blind placebo controlled trial comparing the effect of a combined ketorolac and lidocaine paracervical block with a standard lidocaine paracervical block on procedure related pain with office hysteroscopies.
Official title: Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy: a Randomized Controlled Trial
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
60
Start Date
2026-07-01
Completion Date
2027-12-31
Last Updated
2026-10-22
Healthy Volunteers
Yes
Interventions
paracervical block
paracervical block with office hysteroscopy
Lidocaine
Dosage: 20 mL of 1% lidocaine
ketorolac
Dosage: 2 mL (30 mg) of ketorolac
Locations (1)
Mount Sinai
New York, New York, United States